Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Thromboelastographic Methods in Deciding Therapy on Moderate to Severe COVID-19

NCT05343728 is registered in ClinicalTrials.gov with Indonesia University as lead sponsor.

NCT NCT05343728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05343728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Thromboelastographic Methods in Deciding Therapy on Moderate to Severe COVID-19
Lead sponsor
Indonesia University
Phase
Observational
Overall status
Completed
Start date
October 1, 2020
Completion date
July 9, 2021
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19